United States · FDA National Drug Code directory
naratriptan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 87063-287_586e484f-099e-4e71-e063-6294a90af7d1
- Product NDC
- 87063-287
- Form
- TABLET
- Composition / generic term
- naratriptan
- Labeler
- ASCLEMED USA INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110315
- Source listing expiry
- 20271231
Source-listed ingredients
- NARATRIPTAN HYDROCHLORIDE — 1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 9 TABLET in 1 BLISTER PACK (87063-287-09) · 87063-287-09
- 12 TABLET in 1 BOTTLE (87063-287-12) · 87063-287-12
- 30 TABLET in 1 BOTTLE (87063-287-30) · 87063-287-30
- 60 TABLET in 1 BOTTLE (87063-287-60) · 87063-287-60
- 90 TABLET in 1 BOTTLE (87063-287-90) · 87063-287-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →